Relation between Dopamine Synthesis Capacity and Cell-Level Structure in Human Striatum: A Multi-Modal Study with Positron Emission Tomography and Diffusion Tensor Imaging

Positron emission tomography (PET) study has shown that dopamine synthesis capacity varied among healthy individuals. This interindividual difference might be due to a difference in the cell-level structure of presynaptic dopaminergic neurons, i.e., cellular density and/or number. In this study, the relations between the dopamine synthesis capacity measured by PET and the parameter estimates in diffusion tensor imaging (DTI) in striatal subregions were investigated in healthy human subjects. DTI and PET studies with carbon-11 labeled L-DOPA were performed in ten healthy subjects. Age-related changes in the above parameters were also considered. Fractional anisotropy showed a significant positive correlation with age in the posterior caudate. There was significant negative correlation between dopamine synthesis capacity and mean diffusivity in the posterior caudate and putamen. Assuming that mean diffusivity reflects the density of wide-spreading axonal terminals in the striatum, the result suggests that dopamine synthesis may be related to the density of dopaminergic neuronal fibers. It is evident that PET/DTI combined measurements can contribute to investigations of the pathophysiology of neuropsychiatric diseases involving malfunction of dopaminergic neurons.

[1]  T. Suhara,et al.  Influence of O-Methylated Metabolite Penetrating the Blood–Brain Barrier to Estimation of Dopamine Synthesis Capacity in Human L-[β-11C]DOPA PET , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  J. Giménez-Amaya,et al.  Distribution of GABAergic Interneurons and Dopaminergic Cells in the Functional Territories of the Human Striatum , 2012, PloS one.

[3]  R. Murray,et al.  Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.

[4]  G. Egan,et al.  Connectivity-based segmentation of the striatum in Huntington's disease: Vulnerability of motor pathways , 2011, Neurobiology of Disease.

[5]  Fumitoshi Kodaka,et al.  Relation between Presynaptic and Postsynaptic Dopaminergic Functions Measured by Positron Emission Tomography: Implication of Dopaminergic Tone , 2011, The Journal of Neuroscience.

[6]  Richa Trivedi,et al.  Quantification of age- and gender-related changes in diffusion tensor imaging indices in deep grey matter of the normal human brain , 2011, Journal of Clinical Neuroscience.

[7]  O. Inoue,et al.  Microdialysis with Radiometric Monitoring of L-[β-11C]DOPA to Assess Dopaminergic Metabolism: Effect of Inhibitors of L-Amino Acid Decarboxylase, Monoamine Oxidase, and Catechol-O-Methyltransferase on Rat Striatal Dialysate , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  A. Stefani,et al.  Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. , 2010, Brain : a journal of neurology.

[9]  H. Forssberg,et al.  Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning , 2010, Proceedings of the National Academy of Sciences.

[10]  S. Haber,et al.  Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. , 2010, Archives of general psychiatry.

[11]  Christer Halldin,et al.  Modulation of striatal dopamine D1 binding by cognitive processing , 2009, NeuroImage.

[12]  Timothy Edward John Behrens,et al.  In vivo evidence for the selective subcortical degeneration in Huntington's disease , 2009, NeuroImage.

[13]  F. Fujiyama,et al.  Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.

[14]  Torsten Rohlfing,et al.  Diffusion tensor imaging of deep gray matter brain structures: Effects of age and iron concentration , 2008, Neurobiology of Aging.

[15]  David H. Miller,et al.  Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation , 2008, Magnetic resonance in medicine.

[16]  Osamu Abe,et al.  Aging in the CNS: Comparison of gray/white matter volume and diffusion tensor data , 2008, Neurobiology of Aging.

[17]  Harumasa Takano,et al.  Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography , 2008, NeuroImage.

[18]  Khader M Hasan,et al.  Diffusion tensor metrics, T2 relaxation, and volumetry of the naturally aging human caudate nuclei in healthy young and middle‐aged adults: Possible implications for the neurobiology of human brain aging and disease , 2008, Magnetic resonance in medicine.

[19]  Harumasa Takano,et al.  Mapping of central dopamine synthesis in man, using positron emission tomography with l-[β-11C]DOPA , 2007, Annals of nuclear medicine.

[20]  Gareth J. Barker,et al.  Diffusion tensor imaging of post mortem multiple sclerosis brain , 2007, NeuroImage.

[21]  Antoni Rodríguez-Fornells,et al.  Age-related water diffusion changes in human brain: A voxel-based approach , 2007, NeuroImage.

[22]  Ryuji Nakao,et al.  Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[&bgr;-11C]DOPA , 2006, Nuclear medicine communications.

[23]  F. Yasuno,et al.  Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with l-[β-11C]DOPA , 2006 .

[24]  V. Runge Advances in magnetic resonance. , 2004, Investigative radiology.

[25]  J. Rinne,et al.  Uptake of 6‐[18F]fluoro‐L‐dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease , 2004, Synapse.

[26]  A. Carlsson,et al.  Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. , 2003, Scandinavian journal of psychology.

[27]  Jarmo Hietala,et al.  Personality traits and striatal dopamine synthesis capacity in healthy subjects. , 2003, The American journal of psychiatry.

[28]  S. Haber,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Yasuyoshi Watanabe,et al.  Automatic synthesis of l-[β-11C]amino acids using an immobilized enzyme column , 2000 .

[30]  E. Perry,et al.  Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine , 1999, Neuroscience.

[31]  R. Arai,et al.  Demonstration of l-dopa decarboxylating neurons specific to human striatum , 1997, Neuroscience Letters.

[32]  S. Young,et al.  Aromaticl-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenousl-DOPA to dopamine , 1995, Brain Research.

[33]  H. Kimura,et al.  Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.

[34]  B. Långström,et al.  Estimation of regional cerebral utilization of [11C]‐L‐3, 4‐dihydroxy‐phenylalanine (DOPA) in the primate by positron emission tomography , 1992, Acta neurologica Scandinavica.

[35]  Toshiharu Nagats,et al.  Genes for human catecholamine-synthesizing enzymes , 1991, Neuroscience Research.

[36]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[37]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[38]  O. Hornykiewicz,et al.  OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN , 1972, Journal of neurochemistry.

[39]  B. Långström,et al.  Brain kinetics of L-[Β-11 C]DOPA in humans studied by positron emission tomography , 2005, Journal of Neural Transmission / General Section JNT.

[40]  H. Braak,et al.  Neuronal types in the striatum of man , 2004, Cell and Tissue Research.

[41]  M. Mutoh,et al.  Automatic synthesis of L-[beta-11C]amino acids using an immobilized enzyme column. , 2000, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[42]  D. Newport,et al.  A Single Scatter Simulation Technique for Scatter Correction in 3D PET , 1996 .

[43]  P. Grangeat,et al.  Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine , 1996, Computational Imaging and Vision.

[44]  B. Långström,et al.  Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography. , 1991, Journal of neural transmission. General section.

[45]  T. Nagatsu,et al.  Genes for human catecholamine-synthesizing enzymes. , 1991, Neuroscience research.

[46]  Yasuyoshi Watanabe,et al.  Multi-enzymatic Synthesis of beta-11C-Labelled L-Tyrosine and L-DOPA. , 1990 .

[47]  K. Samuelsson Acta Chemica Scandinavica スカンジナビアの協力の一例 , 1981 .

[48]  J. Waugh,et al.  Advances In Magnetic Resonance , 1974 .